Chris Gilmore
Directeur Général chez Aprecia Pharmaceuticals Co.
Profil
Chris Gilmore is currently the Chief Executive Officer at Aprecia Pharmaceuticals Co. Prior to this, he obtained an undergraduate degree from the University of Miami in 1991.
Postes actifs de Chris Gilmore
| Sociétés | Poste | Début |
|---|---|---|
Aprecia Pharmaceuticals Co.
 Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Aprecia Pharmaceuticals Co. manufactures and develops drugs. It offers ZipDose and three dimension printing technology platforms. The firm utilizes the 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale. The company was founded in 2003 and is headquartered in Langhorne, PA. | Directeur Général | 17/04/2019 |
Formation de Chris Gilmore
| University of Miami | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aprecia Pharmaceuticals Co.
Aprecia Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Aprecia Pharmaceuticals Co. manufactures and develops drugs. It offers ZipDose and three dimension printing technology platforms. The firm utilizes the 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale. The company was founded in 2003 and is headquartered in Langhorne, PA. | Health Technology |